These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36716578)

  • 1. Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines.
    Marquez-Martinez S; Vijayan A; Khan S; Zahn R
    Curr Opin Immunol; 2023 Feb; 80():102282. PubMed ID: 36716578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
    Marquez-Martinez S; Salisch N; Serroyen J; Zahn R; Khan S
    PLoS One; 2024; 19(4):e0299215. PubMed ID: 38626093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus vector-based vaccine for infectious diseases.
    Sakurai F; Tachibana M; Mizuguchi H
    Drug Metab Pharmacokinet; 2022 Feb; 42():100432. PubMed ID: 34974335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys.
    Collignon C; Bol V; Chalon A; Surendran N; Morel S; van den Berg RA; Capone S; Bechtold V; Temmerman ST
    Front Immunol; 2020; 11():579872. PubMed ID: 33329551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.
    Zhu J; Huang X; Yang Y
    J Virol; 2007 Apr; 81(7):3170-80. PubMed ID: 17229689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innate immune response to adenovirus vectors.
    Muruve DA
    Hum Gene Ther; 2004 Dec; 15(12):1157-66. PubMed ID: 15684693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodominance of Adenovirus-Derived CD8
    Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
    Hrycak CP; Windmann S; Bayer W
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
    Pandey A; Singh N; Vemula SV; Couëtil L; Katz JM; Donis R; Sambhara S; Mittal SK
    PLoS One; 2012; 7(3):e33428. PubMed ID: 22432020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.
    Choi JH; Dekker J; Schafer SC; John J; Whitfill CE; Petty CS; Haddad EE; Croyle MA
    Clin Vaccine Immunol; 2012 Jan; 19(1):84-95. PubMed ID: 22089246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.
    Gu L; Krendelchtchikova V; Krendelchtchikov A; Oster RA; Fujihashi K; Matthews QL
    Virol J; 2014 Jun; 11():112. PubMed ID: 24935650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus.
    Du X; Goffin E; Gillard L; Machiels B; Gillet L
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field.
    Majhen D; Calderon H; Chandra N; Fajardo CA; Rajan A; Alemany R; Custers J
    Hum Gene Ther; 2014 Apr; 25(4):301-17. PubMed ID: 24580050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus sensing by the immune system.
    Atasheva S; Shayakhmetov DM
    Curr Opin Virol; 2016 Dec; 21():109-113. PubMed ID: 27639089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a recombinant adenovirus-vectored vaccine against both infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss).
    Li S; Li X; Yuan R; Chen X; Chen S; Qiu Y; Yang Q; Wang M; Shi J; Zhang S
    Fish Shellfish Immunol; 2023 Jan; 132():108457. PubMed ID: 36455780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviruses as vaccine vectors.
    Tatsis N; Ertl HC
    Mol Ther; 2004 Oct; 10(4):616-29. PubMed ID: 15451446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.
    Hartman ZC; Appledorn DM; Amalfitano A
    Virus Res; 2008 Mar; 132(1-2):1-14. PubMed ID: 18036698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.
    Seregin SS; Amalfitano A
    Expert Opin Biol Ther; 2009 Dec; 9(12):1521-31. PubMed ID: 19780714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.